BREAKING
Earnings Summary: A snapshot of Duke Energy’s Q4 2025 report 20 hours ago Fiserv (FISV) Earnings: 4Q25 Key Numbers 21 hours ago CVS Health (CVS) Q4 2025 revenue rises 8%; adjusted earnings decline 22 hours ago Chegg Q4 2025 Earnings Soar: New Strategy Stuns Market 1 day ago PAL Q4 2025 Earnings Explode: Mergers Pay Off Now 1 day ago Outdoor Holding Company Q3 2026 Earnings Soar 7% 2 days ago Apollo Q4 2025 Earnings Rocket: Historic AUM Breakthrough 2 days ago Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 2 days ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 2 days ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 2 days ago Earnings Summary: A snapshot of Duke Energy’s Q4 2025 report 20 hours ago Fiserv (FISV) Earnings: 4Q25 Key Numbers 21 hours ago CVS Health (CVS) Q4 2025 revenue rises 8%; adjusted earnings decline 22 hours ago Chegg Q4 2025 Earnings Soar: New Strategy Stuns Market 1 day ago PAL Q4 2025 Earnings Explode: Mergers Pay Off Now 1 day ago Outdoor Holding Company Q3 2026 Earnings Soar 7% 2 days ago Apollo Q4 2025 Earnings Rocket: Historic AUM Breakthrough 2 days ago Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 2 days ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 2 days ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 2 days ago
ADVERTISEMENT
Market News

Aphria stock continues to bleed for the second day in a row

Aphria Inc. (NYSE: APHA), which nosedived 23.42% to $6.05 at the end of Monday’s trading session, continued to be in red during pre-market hours on Tuesday. Aphria’s stock plunged on Monday following short sellers Gabriel Grego of Quintessential Capital Management and Nate Anderson of Hindenburg Research raised concerns about the company’s acquisitions. “Aphria – A […]

December 4, 2018 2 min read

Aphria Inc. (NYSE: APHA), which nosedived 23.42% to $6.05 at the end of Monday’s trading session, continued to be in red during pre-market hours on Tuesday. Aphria’s stock plunged on Monday following short sellers Gabriel Grego of Quintessential Capital Management and Nate Anderson of Hindenburg Research raised concerns about the company’s acquisitions.

“Aphria – A Shell Game with a Cannabis Business on the Side”, a report from Hindenburg Research stated that the recent LATAM acquisition appears to be largely worthless. The report also accused that a network of insiders diverted funds from shareholders and put them into their own pockets. Further, it adds that the official registered office of Aphria’s C$145 million Jamaican acquisition is an abandoned building that was sold off by the bank earlier this year.

Marijuana stocks slip after legalization in Canada

According to the report, “Aphria generates a minimum amount of sales relative to its market cap, we believe that the uncovering of this alleged scheme, coupled with a massive asset write-off, would have catastrophic consequences for its share price.” Hindenburg Research and Quintessential Capital Management presented this report in Kase Learning Short Selling Conference on Monday.

ADVERTISEMENT

Monday afternoon Aphria responded to the allegations by saying that the short-seller report is a malicious and self-serving attempt to profit by manipulating Aphria’s stock price at the expense of Aphria’s shareholders. Hindenburg Research replied in a tweet that Aphria had responded to none of its allegations and it stands by the report with 100% conviction.


Shares of Aphria had lost 59% so far in the year-to-date period and 32% in the past one year. The stock dropped more than 10% during the pre-market hours on Tuesday and it plunged to a new 52-week low after the market opened.

ADVERTISEMENT

 

Get access to timely and accurate verbatim transcripts that are published within hours of the event

ADVERTISEMENT